首站-论文投稿智能助手
典型文献
COVID-19 can be called a treatable disease only after we have antivirals
文献摘要:
More than two years have passed since the first cases of coron-avirus disease 2019(COVID-19),caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),were reported.Ever since then,people have been striving to turn COVID-19 into a pre-ventable and treatable disease.The triumph of vaccines has led to a significant decrease in symptomatic illness,severe and critical disease,and death.Nonetheless,the efficacy of vaccines has been affected by virus evolution and the emergence of new variants,and global access is sub-optimal[1].Meanwhile,antibody responses to vaccination are poor in immunosuppressed patients[2],exactly the population most at risk of severe or critical COVID-19.Therefore,vaccines alone are not enough and potent treatments are needed.Whilst suppressing hyperinflammation stimulated by SARS-CoV-2 has been a breakthrough in hospitalized patients[3],progress is also needed in antiviral therapy for COVID-19.
文献关键词:
作者姓名:
Xueyang Zhang;Peter Horby;Bin Cao
作者机构:
Tsinghua University School of Medicine,Beijing 100084,China;Pandemic Sciences Centre,University of Oxford,Oxford OX3 7LG,UK;Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,National Clinical Research Center for Respiratory Diseases,National Center for Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China;Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Beijing 100029,China;Tsinghua University-Peking University Joint Center for Life Sciences,Beijing 100084,China
引用格式:
[1]Xueyang Zhang;Peter Horby;Bin Cao-.COVID-19 can be called a treatable disease only after we have antivirals)[J].科学通报(英文版),2022(10):999-1002
A类:
ventable,triumph,hyperinflammation
B类:
called,treatable,disease,only,after,have,antivirals,More,than,two,years,passed,since,first,cases,caused,by,severe,acute,respiratory,syndrome,coronavirus,SARS,CoV,were,reported,Ever,then,people,been,striving,turn,into,vaccines,has,significant,decrease,symptomatic,illness,critical,death,Nonetheless,efficacy,affected,evolution,emergence,new,variants,global,access,sub,optimal,Meanwhile,antibody,responses,vaccination,are,poor,immunosuppressed,patients,exactly,population,most,risk,Therefore,alone,not,enough,potent,treatments,needed,Whilst,suppressing,stimulated,breakthrough,hospitalized,progress,also,therapy
AB值:
0.600542
相似文献
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma
Ruixuan Chen;Ping Ouyang;Licong Su;Xi Xu;Penghu Lian;Yanqin Li;Qi Gao;Yifan Zhang;Sheng Nie;Fan Luo;Ruqi Xu;Xiaodong Zhang;Xiaoxi Li;Yue Cao;Peiyan Gao;Juanjuan Kang;Jun Wu;Lu Li-National Clinical Research Center for Kidney Disease,State Key Laboratory of Organ Failure Research,Guangdong Provincial Clinical Research Center for Kidney Disease,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Health Management,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Hematology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College(CAMS&PUMC),Beijing 100730,China;Department of Urology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Affiliated Foshan Maternity&Child Healthcare Hospital,Southern Medical University,Foshan 528000,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Radiation Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China
A techno-economic and life cycle assessment for the production of green methanol from CO2:catalyst and process bottlenecks
Tomas Cordero-Lanzac;Adrian Ramirez;Alberto Navajas;Lieven Gevers;Sirio Brunialti;Luis M.Gandía;Andrés T.Aguayo;S.Mani Sarathy;Jorge Gascon-Department of Chemical Engineering,University of the Basque Country(UPV/EHU),PO Box 644,48080 Bilbao,Spain;Centre for Materials Science and Nanotechnology(SMN),Department of Chemistry,University of Oslo,N-0315 Oslo,Norway;King Abdullah University of Science and Technology,KAUST Catalysis Center(KCC),Advanced Catalytic Materials,Thuwal 23955,Saudi Arabia;Department of Science,Public University of Navarre(UPNA),Arrosadía Campus s/n,31006 Pamplona,Spain;Institute for Advanced Materials and Mathematics(InaMat2),Universidad Publica de Navarra(UPNA),Edificio Jerónimo de Ayanz,Campus de Arrosadia,Pamplona-Iru?a 31006,Spain;King Abdullah University of Science and Technology,Clean Combustion Research Center(CCRC),Thuwal 23955,Saudi Arabia
An automated nucleic acid detection platform using digital microfluidics with an optimized Cas12a system
Zhen Sun;Kang-Feng Lin;Ze-Hang Zhao;Yang Wang;Xin-Xin Hong;Jian-Guang Guo;Qing-Yu Ruan;Lian-Yu Lu;Xiao Li;Rui Zhang;Chao-Yong Yang;Bo-An Li-State Key Laboratory of Cellular Stress Biology,Innovation Center for Cell Signaling Network and Engineering Research Center of Molecular Diagnostics of the Ministry of Education,School of Life Sciences,Xiamen University,Xiamen 361005,China;MOE Key Laboratory of Spectrochemical Analysis&Instrumentation,Key Laboratory of Chemical Biology of Fujian Province,State Key Laboratory of Physical Chemistry of Solid Surfaces,Collaborative Innovation Center of Chemistry for Energy Materials,Department of Chemical Engineering,Department of Chemical Biology,College of Chemistry and Chemical Engineering,Xiamen University,Xiamen 361005,China;Department of Thoracic Surgery,The First Affiliated Hospital,Xiamen University,Xiamen 361005,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。